Abstract
Forty-three consecutive patients with polymyalgia rheumatica were studied for serological markers of actual or previous hepatitis B virus infection. Signs of active virus replication, which include HBsAg supported by the presence of HBeAg and anti-HBc in high titres, were not found in any cases. Anti-HBs, a serological sign of previous hepatitis B virus exposure, was present in 16.8%. The prevalence of anti-HBs is strongly age-dependent in the normal population, and its prevalence in polymyalgia rheumatica was not significantly different from the incidence found in other hospital patients. No significantly raised incidence was found in any subgroups, including patients without liver dysfunction. These results do not support the concept that current or previous hepatitis B virus infection plays any role in the pathogenesis of the majority of cases of polymyalgia rheumatica.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bacon P. A., Doherty S. M., Zuckerman A. J. Hepatitis-B antibody in polymyalgia Rheumatica. Lancet. 1975 Sep 13;2(7933):476–478. doi: 10.1016/s0140-6736(75)90547-4. [DOI] [PubMed] [Google Scholar]
- Dickson E. R., Maldonado J. E., Sheps S. G., Cain J. A., Jr Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function. JAMA. 1973 Jun 11;224(11):1496–1498. [PubMed] [Google Scholar]
- Gocke D. J., Hsu K., Morgan C., Bombardieri S., Lockshin M., Christian C. L. Association between polyarteritis and Australia antigen. Lancet. 1970 Dec 5;2(7684):1149–1153. doi: 10.1016/s0140-6736(70)90339-9. [DOI] [PubMed] [Google Scholar]
- Hansson B. G. Age- and sex-related distribution of antibodies to hepatitis B surface and core antigens in a Swedish population. Acta Pathol Microbiol Scand B. 1976 Dec;84B(6):342–346. doi: 10.1111/j.1699-0463.1976.tb01951.x. [DOI] [PubMed] [Google Scholar]
- Krugman S., Overby L. R., Mushahwar I. K., Ling C. M., Frösner G. G., Deinhardt F. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med. 1979 Jan 18;300(3):101–106. doi: 10.1056/NEJM197901183000301. [DOI] [PubMed] [Google Scholar]
- Levo Y., Gorevic P. D., Kassab H. J., Zucker-Franklin D., Franklin E. C. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med. 1977 Jun 30;296(26):1501–1504. doi: 10.1056/NEJM197706302962605. [DOI] [PubMed] [Google Scholar]
- Malmvall B. E., Bengtsson B. A. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol. 1978;7(3):154–158. doi: 10.3109/03009747809095645. [DOI] [PubMed] [Google Scholar]
- Müller-Schoop J., Gerber N., Knoblauch M. Vaskulitis bei Hepatitis-B-Infektion. Schweiz Med Wochenschr. 1977 Apr 16;107(15):523–525. [PubMed] [Google Scholar]
- Nielsen J. O., Dietrichson O., Juhl E. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. Lancet. 1974 Oct 19;2(7886):913–915. doi: 10.1016/s0140-6736(74)91127-1. [DOI] [PubMed] [Google Scholar]
- Skinhöj P., Hansen J. F. Preparation and characterization of hepatitis B-antigen for radioimmunoassay. Scand J Clin Lab Invest. 1973 Nov;32(3):199–203. doi: 10.3109/00365517309082459. [DOI] [PubMed] [Google Scholar]
- Skinhöj P., Nielsen J. O., Dietrichson O. Serological evidence of hepatitis B infection in patients with chronic liver diseases: radioimmunoassay of HBsAg and anti-HBs. Scand J Gastroenterol. 1977;12(5):615–619. doi: 10.3109/00365527709181343. [DOI] [PubMed] [Google Scholar]
- Skinhöj P., Thulstrup H. Hepatitis-associated antigen. Qualitative and quantitative determination. Scand J Clin Lab Invest. 1971 Feb;27(1):61–66. doi: 10.3109/00365517109080190. [DOI] [PubMed] [Google Scholar]
- Trepo C., Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang. 1970 Sep-Oct;19(3):410–411. [PubMed] [Google Scholar]